People on GLP-1 medicines reported nail issues, including nails separating from the skin, more often than non-users in a new survey.
Recap by typeshit. Post by @science__sphere on Instagram.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Chosun Ilbo got a look inside the plant, where AI systems and robots run much of the Wegovy production line.
The Swiss drugmaker is licensing an investigational obesity candidate from the Chinese biotech, adding to its push into the weight loss drug race.
Loading…